Indapen Sr

Indapamide, the active ingredient in Indapen Sr, is a thiazide-like diuretic presented as an oral tablet for oral use. It treats hypertension and edema in adult patients.

GNH USA supplies Indapen Sr as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is a thiazide‑like diuretic used in cardiovascular and renal conditions.

Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. Edema: increases urinary excretion of sodium and water, decreasing tissue swelling. Heart failure (off‑label): assists in fluid management when combined with other therapies.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urinary frequency - Electrolyte disturbances such as low potassium - Muscle cramps or weakness - Fatigue

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Hyponatremia or hyperuricemia - Allergic reactions including rash or angioedema - Blood dyscrasias such as leukopenia - Pancreatitis - Acute renal failure

When prescribing Indapamide, clinicians should consider several safety measures.

Monitor electrolytes: check potassium and sodium levels regularly. Assess renal function: evaluate creatinine and eGFR before and during therapy. Use caution in gout: may increase serum uric acid. Avoid in severe hepatic impairment: impaired metabolism can raise drug exposure. Adjust in elderly patients: start with the lowest effective dose. Store at below 25°C: keep in the original pack, protect from moisture.

Indapamide can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity increases. - NSAIDs: may reduce diuretic efficacy and impair renal function. - ACE inhibitors or ARBs: heightened risk of hypotension and renal impairment.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may enhance hypoglycemic effect. - Corticosteroids: can exacerbate fluid retention. - Quinolone antibiotics: may increase risk of QT prolongation. - Beta‑blockers: additive blood‑pressure lowering effect. - Digoxin: altered serum levels due to electrolyte changes.